Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Huangkui Capsule is a single medicament of traditional Chinese medicine consists of Abelmoschus manihot and has been widely used to treat kidney disease. The purpose of this study is to evaluate the safety and efficacy of Abelmoschus manihot for treating chronic kidney disease in large scale samples with long time take.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese PLA General Hospital
• Collaborator: Jiangsu Suzhong Pharmaceutical Group Co., Ltd.

Criteria

Inclusion Criteria:

• Clinical diagnosed as non-ESRD chronic kidney disease (stage I-IV)

• Blood pressure of ≤140/90mmHg

• Obtaining the signed informed consent from patients

Exclusion Criteria:

• Be allergic to Huangkui Capsule

• Combined with severe primary diseases of heart, brain, liver and hematopoietic system and so on, or other serious diseases which can affect the patient's life

• Lactation, pregnancy or plans pregnancy during the study period

• Participating in another clinical study in the same period